Articles

U.S. productivity slumps in first quarter

Unit labor costs soar by most in a year

Jobless claims inch up to 208,000. Layoffs still extremely low.

The number of Americans who applied for unemployment benefits last week barely rose to 208,000, indicating that layoffs remain at extremely low levels associated with a sound economy.

Wrangler parent Kontoor’s stock jumps toward a 3-year high after earnings beat

Revenue fell for both Wrangler and Lee jeans brands, mostly because of retailers reducing inventory.

ConocoPhillips’s production narrowly beats analyst estimate, but profit falls slightly short

Shares ticked up premarket as the company says it plans to return $9 billion to shareholders through dividends and stock buybacks in 2024.

Cardinal Health’s stock falls on mixed quarterly results

Cardinal Health’s shares fell premarket Thursday after the company reported mixed quarterly results but raised its full-year profit outlook.

Corporate insiders are on a buyers’ strike — signaling more downward pressure on stocks

Executives in the know aren’t biting at discounted share prices.

Peloton replaces CEO after 90% stock slide during his tenure, plans more layoffs

Barry McCarthy is stepping down as Peloton’s CEO, the connected-fitness company announced on Thursday morning.

Highly ranked manager who bet on Mag 7 giants looks to these second-order winners from AI

The MainStay Winslow Large Cap Growth fund owes a lot of its returns to Big Tech. Co-portfolio manager Justin Kelly is hot on the hunt for new winners. Here are some ideas.

With more of us living longer, traditional retirement plans just won’t cut it

Whatever your age, you need to invest more in your future to ensure you age well.

My grandmother’s house was split between her 10 kids almost 50 years ago. How do we figure out the cost basis?

If the property has been held for a long time things can become complicated.

What if you could take your existing mortgage with you to a new house?

Here’s the key that could unlock the U.S. housing market for buyers and sellers.

Novartis to pay up to $1.75 billion for U.S. cancer-focused biotech

Novartis on Thursday said it will pay up to $1.75 billion for a U.S. biotech focused on cancer.
1 1,401 1,402 1,403 1,404 1,405 2,511